A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Clinical trial NCT03273842 · COMPLETED
Trial details
- NCT number
- NCT03273842
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2018-07-25
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.